Skip to main content

Validation of tissue microarray technology in breast carcinoma.

Camp RL, Charette LA, Rimm DL

Publication: Lab Invest (2000) • Vol 80 • Page 1943-9PMID: 11140706View on PubMed

Purpose

The purpose of this paper was to determine the effects of storage and using tissue microarray versus whole-sections on immunohistochemical (IHC) staining of breast carcinoma specimens.

Conclusion

Tissue microarray estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) analysis agreed with whole-section IHC results for 35 out of 36, 34 out of 35, and 33 out of 34 cases, respectively. For seven specimens (3 ER, 2 PR, and 2 HER2), discrepant results were obtained between cores taken from the periphery of the tumor and those taken from the center, suggesting both types of cores should be analyzed for an accurate representation of the whole specimen. Analysis of just one disk per specimen matched whole-section IHC staining 90% of the time while analysis of 2 disks matched whole-section IHC results greater than 95% of the time. ER, PR, and HER2 staining was observed in specimens stored for up to 68 years, but interestingly, nuclear DAPI staining was decreased in specimens stored for more than 48 y.

Studies (1)

Purpose

The purpose of this study was to determine the effects of storage (at 18-37 degrees C) and using tissue microarrays rather than whole-sections for IHC staining of breast carcinoma specimens.

Summary of Findings

For 35 out of 36 cases where a minimum of 2 scorable disks were present on the microarray, microarray ER analysis agreed with whole-section IHC results. The one discrepant case was borderline-negative (5% staining) by whole-section IHC and averaged as ER-positive from the tissue microarray (28% staining). Discrepant results were also obtained for PR and HER2 expression between whole-section IHC and microarray analysis in 1 of 35 and 1 of 34 cases, respectively. For seven specimens (3 ER, 2 PR, and 2 HER2), discrepant results were obtained between cores taken from the periphery of the tumor and those taken from the center, suggesting both types of cores should be analyzed for an accurate representation of the whole specimen. Analysis of just one disk per specimen matched whole-section IHC staining 90% of the time while analysis of 2 disks matched whole-section IHC results greater than 95% of the time. ER, PR, and HER2 staining was observed in specimens stored for up to 68 years. A significant decrease in the percentage of ER positive specimens was seen in the cohort stored for 59-68 y. However, the authors note that they could not determine whether storage affected the stability of ER as the specimens from that decade may happen to be truly ER negative. Interestingly, nuclear DAPI staining was decreased in specimens stored for more than 48 y.
  • Biospecimens

    TissueBreast
  • Preservation Types

    Formalin
  • Diagnoses

    NeoplasticCarcinoma
  • Platforms

    ProteinImmunohistochemistry
    ProteinTissue microarray
    MorphologyFluorescent microscopy
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    Biospecimen Aliquots and ComponentsAliquot size/volume
    10 disks
    2 disks
    3 disks
    4 disks
    5 disks
    6 disks
    7 disks
    8 disks
    9 disks
    Biospecimen Aliquots and ComponentsBiospecimen heterogeneity
    Biospecimen core
    Biospecimen periphery
    Biospecimen Aliquots and ComponentsType of slide
    Tissue microarray section
    Whole tissue section
    StorageStorage duration
    1 y
    19-28 y
    2-8 y
    29-38 y
    39-48 y
    49-58 y
    59-68 y
    9-18 y
    Tissue microarray SpecificTargeted peptide/protein
    Cytokeratin
    ER
    HER2
    Ki-67
    PR
    Immunohistochemistry SpecificTargeted peptide/protein
    Cytokeratin
    ER
    HER2
    Ki-67
    PR